Cyclooxygenase-2 expression and its association with thyroid lesions

Archives of Medical Science

Volumn 6, Issue 5, 2010, Pages 653-657

  Krawczyk Rusiecka, Kinga ^a,b   Lewiński, Andrzej ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Cyclooxygenase 2 gene; Expression; Thyroid lesions

Indexed keywords

CYCLOOXYGENASE 2; MOLECULAR MARKER; NONSTEROID ANTIINFLAMMATORY AGENT;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; COLON CANCER; DRUG USE; ENZYME ACTIVITY; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; THYROID CANCER; THYROIDITIS;

EID: 78349235358     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.17076     Document Type: Review

References (60)

1. Radi ZA. Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol 2009; 37: 34-46.
2. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-6.
3. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-12.
4. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992; 89: 7384-8.
5. Herschmann HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299: 125-40.
6. Bell CD, Vidal S, Kovacs K, Horvath E, Rotondo F. An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes. Endocr Pathol 2002; 13: 331-40.
7. Quidville V, Segond N, Lausson S, Frenkian M, Cohen R, Jullienne A. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Prostaglandins Other Lipid Mediat 2006; 81: 14-30.
8. Ristimäki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996; 318: 325-31.
9. Lasa M, Brook M, Saklatvala J, Clark AR. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 2001; 21: 771-80.
10. Nieminen R, Vuolteenaho K, Riutta A, et al. Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability. Eur J Pharmacol 2008; 587: 309-16.
11. Hung WC, Chang HC. Methanolic extract of adlay seed suppresses COX-2 expression of human lung cancer cells via inhibition of gene transcription. J Agric Food Chem 2003; 51: 7333-7.
12. Califano D, Rizzo C, D'Alessio A, et al. Signaling through Ras is essential for ret oncogene - induced cell differentiation in PC12 cells. J Biol Chem 2000; 275: 19297-305.
13. Jones DA, Carlton DP, Mclntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response tocytokines. J Biol Chem 1993; 268: 9049-54.
14. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
15. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-40.
16. Sawaoka H, Tsuji S, Tsujii M, et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999; 79: 1469-77.
17. Fosslien E. Molecular pathology of cyclooxygenase-2-cancer-induced angiogenesis. Ann Clin Lab Sci 2001; 31: 325-48.
18. Siironen P, Ristimäki A, Narko K, et al. VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr Relat Cancer 2006; 13: 465-73.
19. Soh EY, Duh QY, Sobhi SA, et al. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab 1997; 82: 3741-7.
20. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59: 991-4.
21. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998; 90: 455-60.
22. Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001; 7: 429-34.
23. van Rees BP, Saukkonen K, Ristimaki A, et al. Cyclooxygenase-2expression during carcinogenesis in the human stomach. J Pathol 2002; 196: 171-9.
24. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001; 7: 558-61.
25. Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic and mammary tumors. Cancer 2000; 89: 2637-45.
26. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
27. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schrör K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59: 198-204.
28. Agoff SN, Brentnall TA, Crispin DA, et al. The role of cyclooxygenase-2 in ulcerative colitis-associated neoplasia. Am J Pathol 2000; 157: 737-45.
29. Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999; 29: 688-96.
30. Hayashi N, Yamamoto H, Hiraoka N, et al. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology 2001; 34; 638-50.
31. Wolf H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998; 58: 4997-5001.
32. Sung JJ, Leung WK, Go MY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000; 157: 729-35.
33. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-9.
34. Okami J, Yamamoto H, Fujiwara Y, et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999; 5: 2018-24.
35. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's and associated adenocarcinomas. Cancer Res 1998; 58: 2929-34.
36. Mazhar D, Gillmore R, Waxmann J. COX and cancer. Q J Med 2005; 98: 711-8.
37. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333: 609-14.
38. Tiano H, Chulada P, Spalding J, et al. Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin. Proc Am Assoc Cancer Res 1997; 38: 1727.
39. Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the ApcΔ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001; 61: 1733-40.
40. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
41. Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of PI3k/Akt Pathway. J Am Coll Surg 2007; 204: 764-75.
42. Lemoine NR, Mayall ES, Wyllie FS, et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989; 4: 159-64.
43. Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 1990; 4: 1474-9.
44. Sheng H, Willimas CS, Shao J, Liang P, DuBois RN, Beauchamp RD. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 1998; 273: 22120-7.
45. Sheng H, Shao J, Dixon DA, et al. TGF-1 enhances Ha-Ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 2000; 275: 6628-35.
46. Lam KY, Montone KT, Nolan Ka, LiVolsi VA. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication of the histological implications. Human Pathol 1998; 29: 565-8.
47. Ito Y, Yoshida H, Nakano K, et al. Cyclooxygenase-2 expression in thyroid neoplasms. Histopathology 2003; 42: 492-7.
48. Kajita S, Ruebel KH, Casey MB, Nakamura N, Lloyd RV. Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth. Mod Pathol 2005; 18: 221-7.
49. Garcia-Gonzales M, Abdulkader I, Vazquez Boquete A, Neo X M, Forteza J, Cameselle-Teijeiro J. Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland. Virch Arch 2005; 447: 12-7.
50. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope 2002; 112: 238-42.
51. Lee KJ, Jung YS, Kim WH, Yoon TI, Joo HJ, Soh EY. Cyclooxygenase-2 expression in human thyroid disease. J Endocrinol Invest 2008; 31: 111-8.
52. Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ III. Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 2002; 87: 358-63.
53. Nose F, Ichikawa T, Fujiwara M, Okayasu I. Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors. Am J Clin Pathol 2002; 117: 546-51.
54. Haynik DM, Prayson RA. Immunohistochemical expression of cyclooxygenase 2 in follicular carcinomas of the thyroid. Arch Pathol Lab Med 2005; 129: 736-41.
55. Fuhrer D, Eszlinger M, Karger S, et al. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur J Endocrinol 2005; 152: 785-90.
56. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasm to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955; 70: 291-7.
57. Repplinger D, Barger A, Zhang Yi-Wei, Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 2008; 150: 49-52.
58. Berg J, Stöcher M, Bogner S, Wölfl S, Pichler R, Stekel H. Inducible cyclooxygenase-2 gene expression in the human thyroid epithelial cell line Nthy-ori3-1. Inflamm Res 2000; 49: 139-43.
59. Lo CY, Lam KY, Leung PP, Luk JM. High prevalence of cylooxygenase 2 expression in papillary thyroid carcinoma. Eur J Endocrinol 2005; 152: 545-50.
60. Hamberger B, Gharib H, Melton LJ, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 1982; 73: 381-4.